Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 126K 117K 108K 202K 13.74M 206K 1.39M 544K 6.79M 538K 527K 23.49M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.16M 18.8M 17.27M 32.37M 2.2B 32.91M 222M 87.05M 1.09B 86.15M 84.29M 3.76B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.02% | +9.54% | +20.51% | +2.93% | 208B | ||
| +1.30% | -1.02% | -3.13% | -22.02% | 138B | ||
| +1.39% | +2.44% | -27.04% | +11.82% | 126B | ||
| +1.21% | +5.23% | -56.60% | -12.50% | 67.64B | ||
| +0.77% | -1.55% | +4.60% | +1.22% | 47.81B | ||
| +1.01% | +1.61% | -25.12% | -32.86% | 45.03B | ||
| +1.92% | +7.89% | +16.94% | +10.96% | 38.94B | ||
| +3.42% | +7.37% | +26.72% | +34.60% | 36.45B | ||
| +2.90% | +5.21% | -24.06% | -5.66% | 29.29B | ||
| Average | +1.80% | +1.03% | -7.46% | -1.28% | 81.92B | |
| Weighted average by Cap. | +1.81% | +1.40% | -4.59% | -2.29% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.42M 1.3M 2.44M 166M 2.48M 16.75M 6.56M 81.93M 6.49M 6.35M 283M | 1.98M 1.74M 1.62M 1.49M 2.79M 190M 2.84M 19.15M 7.5M 93.69M 7.42M 7.26M 324M |
| Net income | -16.08M -14.12M -13.17M -12.1M -22.68M -1.54B -23.06M -156M -60.99M -762M -60.35M -59.05M -2.63B | -29.31M -25.75M -24.02M -22.07M -41.35M -2.81B -42.04M -284M -111M -1.39B -110M -108M -4.8B |
| Net Debt | 20.53M 18.03M 16.82M 15.45M 28.95M 1.97B 29.44M 199M 77.86M 972M 77.05M 75.39M 3.36B | 22.8M 20.03M 18.69M 17.17M 32.17M 2.19B 32.71M 221M 86.51M 1.08B 85.61M 83.76M 3.74B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















